Results of BACE1-Inhibitor Clinical Trials Confirm Key Predictions for App-Independent Generation of Beta-Amyloid in Sporadic AD

doi 10.20944/preprints201804.0079.v1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Β-Site APP-cleaving Enzyme 1 (BACE1); Β-Amyloid (Aβ)

Science-Business eXchange
2010English

Novel Role of RanBP9 in BACE1 Processing of Amyloid Precursor Protein and Amyloid Β Peptide Generation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2009English

Effective Screen for Amyloid Β Aggregation Inhibitor Using Amyloid Β-Conjugated Gold Nanoparticles

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2010English

Total Aβ42/Aβ40 Ratio in Plasma Predicts Amyloid-Pet Status, Independent of Clinical AD Diagnosis

Neurology
Neurology
2020English

Transgenic Mouse Model of Alzheimer's Disease (AD) Expressing Human Β-Site APP Cleaving Enzyme 1 (BACE1)

Science-Business eXchange
2014English

Outcome Markers for Clinical Trials in Cerebral Amyloid Angiopathy

The Lancet Neurology
Neurology
2014English

Destruxin E Decreases Beta-Amyloid Generation by Reducing Colocalization of Beta-Amyloid-Cleaving Enzyme 1 and Beta-Amyloid Protein Precursor

Neurodegenerative Diseases
Neurology
2009English

Expression of APP, BACE1, AChE and ChAT in an AD Model in Rats and the Effect of Donepezil Hydrochloride Treatment

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2012English

Interaction of the Cytosolic Domains of sorLA/LR11 With the Amyloid Precursor Protein (APP) and Beta-Secretase Beta-Site APP-Cleaving Enzyme

Journal of Neuroscience
Neuroscience
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy